Ms Rita Purcell:

In relation to inspection, most big UK pharmaceutical companies are exporting to the European Union and must, therefore, comply with EU law, no matter that they are based in the UK. They are also subject to EU inspections. Whether there will be resources is a second issue. It is not even that there is an incentive to stay aligned, but that these companies must stay aligned if they want to continue to gain access to the EU.